rs10040165

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_032119.4(ADGRV1):​c.6952-10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.34 in 1,584,942 control chromosomes in the GnomAD database, including 94,667 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8057 hom., cov: 32)
Exomes 𝑓: 0.34 ( 86610 hom. )

Consequence

ADGRV1
NM_032119.4 intron

Scores

2
Splicing: ADA: 0.0001884
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.469

Publications

15 publications found
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
ADGRV1 Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2C
    Inheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 4
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 5-90692595-G-A is Benign according to our data. Variant chr5-90692595-G-A is described in ClinVar as Benign. ClinVar VariationId is 46358.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.463 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADGRV1NM_032119.4 linkc.6952-10G>A intron_variant Intron 31 of 89 ENST00000405460.9 NP_115495.3 Q8WXG9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADGRV1ENST00000405460.9 linkc.6952-10G>A intron_variant Intron 31 of 89 1 NM_032119.4 ENSP00000384582.2 Q8WXG9-1

Frequencies

GnomAD3 genomes
AF:
0.315
AC:
47886
AN:
151806
Hom.:
8044
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.216
Gnomad AMI
AF:
0.356
Gnomad AMR
AF:
0.471
Gnomad ASJ
AF:
0.276
Gnomad EAS
AF:
0.387
Gnomad SAS
AF:
0.321
Gnomad FIN
AF:
0.334
Gnomad MID
AF:
0.269
Gnomad NFE
AF:
0.333
Gnomad OTH
AF:
0.348
GnomAD2 exomes
AF:
0.348
AC:
78709
AN:
226266
AF XY:
0.341
show subpopulations
Gnomad AFR exome
AF:
0.204
Gnomad AMR exome
AF:
0.565
Gnomad ASJ exome
AF:
0.259
Gnomad EAS exome
AF:
0.361
Gnomad FIN exome
AF:
0.332
Gnomad NFE exome
AF:
0.327
Gnomad OTH exome
AF:
0.354
GnomAD4 exome
AF:
0.342
AC:
490657
AN:
1433018
Hom.:
86610
Cov.:
29
AF XY:
0.340
AC XY:
242185
AN XY:
711990
show subpopulations
African (AFR)
AF:
0.202
AC:
6586
AN:
32682
American (AMR)
AF:
0.553
AC:
21803
AN:
39432
Ashkenazi Jewish (ASJ)
AF:
0.269
AC:
6877
AN:
25576
East Asian (EAS)
AF:
0.432
AC:
16866
AN:
39054
South Asian (SAS)
AF:
0.322
AC:
26224
AN:
81396
European-Finnish (FIN)
AF:
0.340
AC:
17978
AN:
52908
Middle Eastern (MID)
AF:
0.274
AC:
1562
AN:
5710
European-Non Finnish (NFE)
AF:
0.340
AC:
372927
AN:
1096872
Other (OTH)
AF:
0.334
AC:
19834
AN:
59388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
13386
26773
40159
53546
66932
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12124
24248
36372
48496
60620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.315
AC:
47905
AN:
151924
Hom.:
8057
Cov.:
32
AF XY:
0.319
AC XY:
23647
AN XY:
74230
show subpopulations
African (AFR)
AF:
0.215
AC:
8926
AN:
41454
American (AMR)
AF:
0.472
AC:
7205
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.276
AC:
956
AN:
3466
East Asian (EAS)
AF:
0.387
AC:
1995
AN:
5156
South Asian (SAS)
AF:
0.322
AC:
1547
AN:
4810
European-Finnish (FIN)
AF:
0.334
AC:
3518
AN:
10524
Middle Eastern (MID)
AF:
0.276
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
0.333
AC:
22629
AN:
67938
Other (OTH)
AF:
0.344
AC:
725
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1668
3335
5003
6670
8338
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.335
Hom.:
12058
Bravo
AF:
0.327
Asia WGS
AF:
0.343
AC:
1193
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jun 19, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 2C Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Febrile seizures, familial, 4;C2931213:Usher syndrome type 2C Benign:1
Aug 11, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
14
DANN
Benign
0.63
PhyloP100
-0.47
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00019
dbscSNV1_RF
Benign
0.018
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10040165; hg19: chr5-89988412; COSMIC: COSV67980893; COSMIC: COSV67980893; API